Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Biomedicines|July 2, 2021
Oncolytic Virus Immunotherapy: Showcasing Impressive Progress in Special Issue IIZong-Sheng Guo
Biochimica Et Biophysica Acta. Reviews on Cancer|September 27, 2021
PDLIM2: Signaling pathways and functions in cancer suppression and host immunityZong Sheng Guo, Zhaoxia Qu
Biomedicines|August 25, 2017
Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for CancerZong Sheng Guo, David L Bartlett
Frontiers in Oncology|May 1, 2014
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor ImmunityZong Sheng Guo, Zuqiang Liu, David L Bartlett
Molecular and Cellular Biology|February 18, 2004
DNA methylation may restrict but does not determine differential gene expression at the Sgy/Tead2 locus during mouse developmentKotaro J Kaneko, Theo Rein, Zong-Sheng Guo, et al.
Biomedicines|July 16, 2020
Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer ImmunotherapyZong Sheng Guo, Michael T Lotze, Zhi Zhu, et al.
Molecular Therapy Oncolytics|May 15, 2020
<i>In Situ</i> Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2Weilin Liu, Enyong Dai, Zuqiang Liu, et al.
Molecular Cancer|December 21, 2021
Epigenetic modulation of antitumor immunity for improved cancer immunotherapyEnyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Biochemical Pharmacology|April 2, 2008
Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathwayYoung-Ho Kim, Dae-Hee Lee, Jae-Hoon Jeong, et al.
Molecular Cancer|October 11, 2022
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathwaysZhi Zhu, A J Robert McGray, Weijian Jiang, et al.
Pageof 5